Does Testosterone Improve Function in Hypogonadal Older Men

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00304213

Enrollment

Registered

2006-03-17

Start date

2006-03-31

Completion date

2009-04-30

Last updated

2015-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogonadism

Keywords

hypogonadism, testosterone, aging, Total testosterone < 300 ng/dL, Bioavailable testosterone < 70 ng/dL

Brief summary

This is a randomized controlled trial of testosterone replacement therapy in hypogonadal men age \> 60 years. The goal is to assess the safety and efficacy of TRT in men age \> 60 years.

Interventions

DRUGTestosterone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

MALE

Age

60 Years to 80 Years

Inclusion criteria

age 60-80 yrs serum total testosterone \< 300 ng/dL serum bioavailable testosterone \< 70 ng/dL

Exclusion criteria

unable to provide informed consent history of prostate or breast cancer untreated sleep apnea

Design outcomes

Primary

Measure	Time frame
Physical function	—
Cognitive function	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026